SURVIVAL rateGLIOMASGLIOBLASTOMA multiformeNOSOLOGYBRAIN tumorsIntroduction: Glioblastoma, as the most common and lethal primary malignant brain tumor, has estimated mean survival of 15 months. GBM is reported more in men. Malignant glioma is the cause of 2.5% of cancer deaths. The standard therapy ...
摘要: These findings illustrate an improved 3-year survival rate for GBM patients from 2004 to 2013 with a concurrent increase in trimodal treatment administration despite more adverse patient presenting characteristics.关键词:Glioblastoma multiforme Long-term survival Prognosis Trends Treatment MGMT ...
Glioblastomas are invasive therapy resistant brain tumors with extremely poor prognosis. The Glioma initiating cell (GIC) population contributes to therapeutic resistance and tumor recurrence. Targeting GIC-associated gene candidates could significantly
(a) For each patientk, the patient’s hazard rateλk(t) is associated with the baseline hazard rateλ0(t) and this patient’s exon-inclusion levelψk. The association of exon-inclusion level with patient survival is estimated by the survival coefficientβ. The exon-inclusion levelψkis est...
Multivariate analysis of prognostic factors and survival in patients with "glioblastoma multiforme" The aim of this study was to evaluate the survival of patients with "glioblastoma multiforme", to analyse the prognostic factors influencing the survival rate and to review recent results in the literatur...
Figure 5 The survival rate of patients with radiation therapy. The survival of patients received radiation in TCGA (A) and E-TABM-302 datasets (B). Full size imageAltered pathways in high and low risk score group To investigate the potential altered pathways in the high risk group, Gene Se...
The conditional probabilities of survival in patients with anaplastic astrocytoma or glioblastoma multiforme By the use of conditional probabilities of survival, we studied the yearly survival rates for individual tumor survivors. Conditional survival rate was est... CL Lin,AS Lieu,KS Lee,... - 《...
Id-1 expression promotes cell survival through activation of NF-?B signalling pathway in prostate cancer cells. The growth-promoting effect of Id-1 (inhibitor of differentiation/DNA binding) has been demonstrated in a number of human cancers. However, the mechanisms ... Ling,Ming-Tat,Wang,.....
Glioblastoma multiforme is the most common primary malignant brain tumour in adults with an incidence rate of 3.7 per 100,000 person-years, though geographical variation exists1. Despite an increasing understanding of the underlying pathophysiology, glioblastoma remains an incurable disease with high morta...
While the 5-year survival rate for local and regional prostate cancer is nearly 100%, it decreases dramatically for advanced tumours. Accessibility to health care is an important factor for cancer prognosis. The U.S. Military Health System (MHS) provides universal health care to its beneficiaries...